Dexcom DXCM recently released its 2026 "State of Type 2 Report: Global Access and Attitudes to Diabetes Technology" ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD). The report highlights significant gaps in continuous glucose monitoring (CGM) awareness and access while pointing to growing potential for combining CGM with GLP-1 therapies. Dexcom also partnered with Team Novo Nordisk, an all-diabetic professional cycling team principally sponsored by Novo Nordisk NVO, demonstrating its focus on expanding awareness and adoption of CGM technology.
Головну думку ми показуємо публічно. Створіть безкоштовний акаунт, щоб читати повну статтю, зберігати її, обговорювати та поєднувати з ринковим і OSINT-контекстом.